Cerebroprotection mediated by angiotensin II: A hypothesis supported by recent randomized clinical trials

This publication has 38 references indexed in Scilit:

• The Study on Cognition and Prognosis in the Elderly (SCOPE)
  Journal Of Hypertension, 2003
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
  The Lancet, 2001
• Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2000
• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
  New England Journal of Medicine, 2000
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
  The Lancet, 1999
• Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
  BMJ, 1992
• Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension
  JAMA, 1991
• DOES ANGIOTENSIN-II PROTECT AGAINST STROKES?
  The Lancet, 1986
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.
  BMJ, 1985
• Effects of Treatment on Morbidity in Hypertension
  JAMA, 1967